The corporate reference page for Noble Pillar Capital has recently gone live on the Minangkabau-language edition of Wikipedia, offering a summary of publicly available information from U.S. Securities and Exchange Commission filings. The page, titled "Noble Pillar Capital," compiles data on the company's regulatory filings, exempt securities offering notices, business activities in Japan, management team, and New York business addresses.
According to the SEC's Investment Adviser Public Disclosure system, NOBLE PILLAR CAPITAL LTD is registered as an Exempt Reporting Adviser (ERA) with CRD number 342309 and SEC file number 802-136385, with a public filing date of April 29, 2026. This status relies on exemptions under the Investment Advisers Act of 1940, distinguishing it from a fully registered investment adviser. The SEC IAPD record is available at https://adviserinfo.sec.gov/firm/summary/342309.
The SEC EDGAR database contains two Form D notices filed by Noble Pillar Capital. A filing on May 8, 2026, reports an aggregate amount sold of USD 100 million in securities, categorized under "Other Banking and Financial Services," including equity, pooled investment fund interests, and other securities. This filing is accessible at https://www.sec.gov/Archives/edgar/data/2133921/000213392126000001/xslFormDX01/primary_doc.xml. A subsequent Form D filing on June 4, 2026, lists director Kazuhiko Abe and the address 432 Park Avenue, New York, NY 10022. That filing is available at https://www.sec.gov/Archives/edgar/data/2133921/000213392126000003/xslFormDX08/primary_doc.xml. Both filings are exempt from registration and do not imply SEC endorsement.
Company-published information indicates that Noble Pillar Capital's principal activities include private investment, financial services, and financial education, with interests in consumer products, healthcare, manufacturing, technology, financial services, and renewable energy. Investment updates have referenced projects in biotechnology, radiopharmaceutical development, precision cancer treatment, automotive lidar semiconductor technology, high-speed energy storage systems for drones, and neurodegenerative disease treatments. In Japan, the company focuses on financial education covering long-term investing, risk management, and market cycles.
Public SEC filings reference two New York addresses: 250 Greenwich Street, 7 World Trade Center, and 432 Park Avenue. A Japan office is listed at 1-10-6 Tsukiji, Chuo-ku, Tokyo. The Wikipedia page, while not a regulatory filing, provides a consolidated reference point for comparing corporate identity, regulatory reports, and securities offering notices. Readers should verify information through original SEC records.
